ResMed Inc Released its Q2FY2020 Results

  • Feb 01, 2020 AEDT
  • Team Kalkine

ResMed Inc (ASX: RMD) has released its Q2 FY2020 results for the quarter ended 31 December 2019.

  • Revenue went up by 13% to $736.2 million year-over-year and 14% on a constant currency basis.
  • Net operating profit grew by 26%;
  • non-GAAP operating profit soared by 21% to $218.5 million;
  • Reported a balanced growth across product portfolio, software solutions, and global markets.
  • A cash dividend of $0.39 per share was declared by the Board of Directors of RMD.

By the closure of the market on 31 January 2020, the closing price of the share was $25.050, up 3.044% from its previous close.



All pictures are copyright to their respective owner(s) does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK